Anti-Venom Market 2027 By Type, Reptile, Mode of Action | The Insight Partners

Anti-Venom Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Type (Monovalent Antivenom, Polyvalent Antivenom); Reptile (Snake, Scorpion, Spider, Others (If Any)); Mode of Action (Cytotoxic, Neurotoxic, Haemotoxic, Cardiotoxic, Myotoxic, Others (If Any))

Report Code: TIPRE00007741 | No. of Pages: 151 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Antivenom or antivenin is a medication made from antibodies that are used to treat certain venomous bites and stings. Antivenom is recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved, and it is given by injection. It includes serum sickness, shortness of breath, and allergic reactions. Antivenom is made by collecting venom from the related animal and injecting small amounts of it into a domestic animal.

MARKET DYNAMICS

The anti-venom market in robust R&D activities is resulting from an increasing number of pipeline products, which may drive the growth of the global anti-venom market. However, the rise in awareness about the presence of anti-venoms has lowered ignorance toward venom-bites, which is restraining the market growth. Moreover, the launch of new products with improved shelf life and extended expiry date is expected to benefit the growth of the market in the forecast period.

MARKET SCOPE

The "Anti-Venom Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in anti-venom market with detailed market segmentation by type, reptile, mode of action and geography. The anti-venom market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in anti-venom market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The anti-venom market is segmented on the basis of type, reptile and mode of action. Based on type the market is segmented as monovalent antivenom and polyvalent antivenom. On the basis of reptile the market is categorized as snake, scorpion, spider and others (if any). On the basis of mode of action the market is categorized as cytotoxic, neurotoxic, haemotoxic, cardiotoxic, myotoxic and others (if any).



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in anti-venom market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anti-venom market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting anti-venom market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the anti-venom market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in anti-venom market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in anti-venom market are anticipated to have lucrative growth opportunities in the future with the rising demand for in anti-venom market in the global market. Below mentioned is the list of few companies engaged in the anti-venom market.

The report also includes the profiles of key in anti-venom market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Alomone Labs, Ltd.
  •  Boehringer Ingelheim International GmbH.
  •  BTG International Ltd.
  •  CSL Limited
  •  Flynn Pharma (Micropharm)
  •  Haffkine Bio-Pharmaceutical Corporation Limited
  •  Laboratorios Silanes
  •  Merck & Co.
  •  Pfizer Inc.
  •  Sigma-Aldrich Co.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anti-Venom Market - By Type
1.3.2 Anti-Venom Market - By Reptile
1.3.3 Anti-Venom Market - By Mode of Action
1.3.4 Anti-Venom Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTI-VENOM MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTI-VENOM MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ANTI-VENOM MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTI-VENOM - GLOBAL MARKET OVERVIEW
6.2. ANTI-VENOM - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTI-VENOM MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MONOVALENT ANTIVENOM
7.3.1. Overview
7.3.2. Monovalent Antivenom Market Forecast and Analysis
7.4. POLYVALENT ANTIVENOM
7.4.1. Overview
7.4.2. Polyvalent Antivenom Market Forecast and Analysis
8. ANTI-VENOM MARKET - REVENUE AND FORECASTS TO 2027 - REPTILE
8.1. OVERVIEW
8.2. REPTILE MARKET FORECASTS AND ANALYSIS
8.3. SNAKE
8.3.1. Overview
8.3.2. Snake Market Forecast and Analysis
8.4. SCORPION
8.4.1. Overview
8.4.2. Scorpion Market Forecast and Analysis
8.5. SPIDER
8.5.1. Overview
8.5.2. Spider Market Forecast and Analysis
8.6. OTHERS (IF ANY)
8.6.1. Overview
8.6.2. Others (If Any) Market Forecast and Analysis
9. ANTI-VENOM MARKET - REVENUE AND FORECASTS TO 2027 - MODE OF ACTION
9.1. OVERVIEW
9.2. MODE OF ACTION MARKET FORECASTS AND ANALYSIS
9.3. CYTOTOXIC
9.3.1. Overview
9.3.2. Cytotoxic Market Forecast and Analysis
9.4. NEUROTOXIC
9.4.1. Overview
9.4.2. Neurotoxic Market Forecast and Analysis
9.5. HAEMOTOXIC
9.5.1. Overview
9.5.2. Haemotoxic Market Forecast and Analysis
9.6. CARDIOTOXIC
9.6.1. Overview
9.6.2. Cardiotoxic Market Forecast and Analysis
9.7. MYOTOXIC
9.7.1. Overview
9.7.2. Myotoxic Market Forecast and Analysis
9.8. OTHERS (IF ANY)
9.8.1. Overview
9.8.2. Others (If Any) Market Forecast and Analysis
10. ANTI-VENOM MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Anti-Venom Market Overview
10.1.2 North America Anti-Venom Market Forecasts and Analysis
10.1.3 North America Anti-Venom Market Forecasts and Analysis - By Type
10.1.4 North America Anti-Venom Market Forecasts and Analysis - By Reptile
10.1.5 North America Anti-Venom Market Forecasts and Analysis - By Mode of Action
10.1.6 North America Anti-Venom Market Forecasts and Analysis - By Countries
10.1.6.1 United States Anti-Venom Market
10.1.6.1.1 United States Anti-Venom Market by Type
10.1.6.1.2 United States Anti-Venom Market by Reptile
10.1.6.1.3 United States Anti-Venom Market by Mode of Action
10.1.6.2 Canada Anti-Venom Market
10.1.6.2.1 Canada Anti-Venom Market by Type
10.1.6.2.2 Canada Anti-Venom Market by Reptile
10.1.6.2.3 Canada Anti-Venom Market by Mode of Action
10.1.6.3 Mexico Anti-Venom Market
10.1.6.3.1 Mexico Anti-Venom Market by Type
10.1.6.3.2 Mexico Anti-Venom Market by Reptile
10.1.6.3.3 Mexico Anti-Venom Market by Mode of Action
10.2. EUROPE
10.2.1 Europe Anti-Venom Market Overview
10.2.2 Europe Anti-Venom Market Forecasts and Analysis
10.2.3 Europe Anti-Venom Market Forecasts and Analysis - By Type
10.2.4 Europe Anti-Venom Market Forecasts and Analysis - By Reptile
10.2.5 Europe Anti-Venom Market Forecasts and Analysis - By Mode of Action
10.2.6 Europe Anti-Venom Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Anti-Venom Market
10.2.6.1.1 Germany Anti-Venom Market by Type
10.2.6.1.2 Germany Anti-Venom Market by Reptile
10.2.6.1.3 Germany Anti-Venom Market by Mode of Action
10.2.6.2 France Anti-Venom Market
10.2.6.2.1 France Anti-Venom Market by Type
10.2.6.2.2 France Anti-Venom Market by Reptile
10.2.6.2.3 France Anti-Venom Market by Mode of Action
10.2.6.3 Italy Anti-Venom Market
10.2.6.3.1 Italy Anti-Venom Market by Type
10.2.6.3.2 Italy Anti-Venom Market by Reptile
10.2.6.3.3 Italy Anti-Venom Market by Mode of Action
10.2.6.4 Spain Anti-Venom Market
10.2.6.4.1 Spain Anti-Venom Market by Type
10.2.6.4.2 Spain Anti-Venom Market by Reptile
10.2.6.4.3 Spain Anti-Venom Market by Mode of Action
10.2.6.5 United Kingdom Anti-Venom Market
10.2.6.5.1 United Kingdom Anti-Venom Market by Type
10.2.6.5.2 United Kingdom Anti-Venom Market by Reptile
10.2.6.5.3 United Kingdom Anti-Venom Market by Mode of Action
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Anti-Venom Market Overview
10.3.2 Asia-Pacific Anti-Venom Market Forecasts and Analysis
10.3.3 Asia-Pacific Anti-Venom Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Anti-Venom Market Forecasts and Analysis - By Reptile
10.3.5 Asia-Pacific Anti-Venom Market Forecasts and Analysis - By Mode of Action
10.3.6 Asia-Pacific Anti-Venom Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Anti-Venom Market
10.3.6.1.1 Australia Anti-Venom Market by Type
10.3.6.1.2 Australia Anti-Venom Market by Reptile
10.3.6.1.3 Australia Anti-Venom Market by Mode of Action
10.3.6.2 China Anti-Venom Market
10.3.6.2.1 China Anti-Venom Market by Type
10.3.6.2.2 China Anti-Venom Market by Reptile
10.3.6.2.3 China Anti-Venom Market by Mode of Action
10.3.6.3 India Anti-Venom Market
10.3.6.3.1 India Anti-Venom Market by Type
10.3.6.3.2 India Anti-Venom Market by Reptile
10.3.6.3.3 India Anti-Venom Market by Mode of Action
10.3.6.4 Japan Anti-Venom Market
10.3.6.4.1 Japan Anti-Venom Market by Type
10.3.6.4.2 Japan Anti-Venom Market by Reptile
10.3.6.4.3 Japan Anti-Venom Market by Mode of Action
10.3.6.5 South Korea Anti-Venom Market
10.3.6.5.1 South Korea Anti-Venom Market by Type
10.3.6.5.2 South Korea Anti-Venom Market by Reptile
10.3.6.5.3 South Korea Anti-Venom Market by Mode of Action
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Anti-Venom Market Overview
10.4.2 Middle East and Africa Anti-Venom Market Forecasts and Analysis
10.4.3 Middle East and Africa Anti-Venom Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Anti-Venom Market Forecasts and Analysis - By Reptile
10.4.5 Middle East and Africa Anti-Venom Market Forecasts and Analysis - By Mode of Action
10.4.6 Middle East and Africa Anti-Venom Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Anti-Venom Market
10.4.6.1.1 South Africa Anti-Venom Market by Type
10.4.6.1.2 South Africa Anti-Venom Market by Reptile
10.4.6.1.3 South Africa Anti-Venom Market by Mode of Action
10.4.6.2 Saudi Arabia Anti-Venom Market
10.4.6.2.1 Saudi Arabia Anti-Venom Market by Type
10.4.6.2.2 Saudi Arabia Anti-Venom Market by Reptile
10.4.6.2.3 Saudi Arabia Anti-Venom Market by Mode of Action
10.4.6.3 U.A.E Anti-Venom Market
10.4.6.3.1 U.A.E Anti-Venom Market by Type
10.4.6.3.2 U.A.E Anti-Venom Market by Reptile
10.4.6.3.3 U.A.E Anti-Venom Market by Mode of Action
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Anti-Venom Market Overview
10.5.2 South and Central America Anti-Venom Market Forecasts and Analysis
10.5.3 South and Central America Anti-Venom Market Forecasts and Analysis - By Type
10.5.4 South and Central America Anti-Venom Market Forecasts and Analysis - By Reptile
10.5.5 South and Central America Anti-Venom Market Forecasts and Analysis - By Mode of Action
10.5.6 South and Central America Anti-Venom Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Anti-Venom Market
10.5.6.1.1 Brazil Anti-Venom Market by Type
10.5.6.1.2 Brazil Anti-Venom Market by Reptile
10.5.6.1.3 Brazil Anti-Venom Market by Mode of Action
10.5.6.2 Argentina Anti-Venom Market
10.5.6.2.1 Argentina Anti-Venom Market by Type
10.5.6.2.2 Argentina Anti-Venom Market by Reptile
10.5.6.2.3 Argentina Anti-Venom Market by Mode of Action
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTI-VENOM MARKET, KEY COMPANY PROFILES
12.1. ALOMONE LABS, LTD.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BOEHRINGER INGELHEIM INTERNATIONAL GMBH.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BTG INTERNATIONAL LTD.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CSL LIMITED
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. FLYNN PHARMA (MICROPHARM)
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. HAFFKINE BIO-PHARMACEUTICAL CORPORATION LIMITED
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. LABORATORIOS SILANES
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MERCK AND CO.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SIGMA-ALDRICH CO.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Alomone Labs, Ltd.
2. Boehringer Ingelheim International GmbH.
3. BTG International Ltd.
4. CSL Limited
5. Flynn Pharma (Micropharm)
6. Haffkine Bio-Pharmaceutical Corporation Limited
7. Laboratorios Silanes
8. Merck & Co.
9. Pfizer Inc.
10. Sigma-Aldrich Co.
TIPRE00007741
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking